Impact of proliferation index on outcome in childhood malignant gliomas: Results in a multi-institutional cohort

Neurosurgery

Volumn 50, Issue 6, 2002, Pages 1238-1245

  Pollack, Ian F ^a,e   Hamilton, Ronald L ^a   Burnham, Judith ^a   Holmes, Emiko J ^e   Finkelstein, Sydney D ^a   Sposto, Richard ^e,f   Yates, Allan J ^b   Boyett, James M ^c   Finlay, Jonathan L ^d   Sutton, Leslie N ^g   Berger, Mitchel S ^g   Mapstone, Timothy B ^g   Rutka, James T ^g   Gilles, Floyd ^g  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e CHILDREN S ONCOLOGY GROUP   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g NONE

Author keywords

Anaplastic astrocytoma; Childhood; Glioblastoma; MIB 1; Prognostic factors; Proliferation index

Indexed keywords

KI 67 ANTIGEN; LOMUSTINE; MONOCLONAL ANTIBODY KI 67; PREDNISONE; VINCRISTINE;

ANTIBODY LABELING; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CELL PROLIFERATION; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; GLIOBLASTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR CLASSIFICATION;

ANTIGENS, NUCLEAR; ASTROCYTOMA; BRAIN NEOPLASMS; CELL DIVISION; CHILD, PRESCHOOL; COHORT STUDIES; GLIOBLASTOMA; GLIOMA; HUMANS; KI-67 ANTIGEN; NUCLEAR PROTEINS; PROGNOSIS; SINGLE-BLIND METHOD; SURVIVAL ANALYSIS;

EID: 0036626526     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200206000-00011     Document Type: Article

References (0)